Cardiotoxicity related to long-term trastuzumab therapy in metastatic breast cancer: the potential role of treatment duration and cardiac risk factors

Breast J. 2015 May-Jun;21(3):318-21. doi: 10.1111/tbj.12412. Epub 2015 Mar 19.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Cardiotoxicity / etiology*
  • Drug Administration Schedule
  • Female
  • Humans
  • Middle Aged
  • Retrospective Studies
  • Trastuzumab / adverse effects*

Substances

  • Trastuzumab